Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood trans - Wikidata - awgldk - TriplyDB

Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood trans

Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood trans

http://www.wikidata.org/entity/Q37339212

about

Redirection of T-cell effector functions for cancer therapy: bispecific antibodies and chimeric antigen receptors.

P2860

Q38096411-1753089B-DF76-4C6F-929D-09504BB2421C

P2860

Activated T cells from umbilical cord blood armed with anti-CD3 × anti-CD20 bispecific antibody mediate specific cytotoxicity against CD20+ targets with minimal allogeneic reactivity: a strategy for providing antitumor effects after cord blood trans

http://www.wikidata.org/entity/Q37339212

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 11 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Activated T cells from umbilic ...... effects after cord blood trans

@en

Activated T cells from umbilic ...... effects after cord blood trans

@nl

type

label

Activated T cells from umbilic ...... effects after cord blood trans

@en

Activated T cells from umbilic ...... effects after cord blood trans

@nl

prefLabel

Activated T cells from umbilic ...... effects after cord blood trans

@en

Activated T cells from umbilic ...... effects after cord blood trans

@nl

P1433

Q37339212-05928B9B-3072-4A7E-8F35-DABDDE9E0659

P1476

Q37339212-15C10635-F5DB-44EC-8D30-B31F4EBAC8D9

P2093

Q37339212-356D16C4-801F-4B30-9838-B84CD1779980

Q37339212-5DCC2BE3-6456-44AD-BDB8-B7B5C3024DD9

Q37339212-6A8ABAAB-555F-4687-B178-24995F3D9C0E

Q37339212-B05BF290-6FFC-4985-AA92-42B93289A3E8

Q37339212-DE88779E-50B0-4049-BBAF-B6969D6230F8

Q37339212-E0CF2068-33F5-4A58-A07E-E63BD0AC5F92

P2860

Q37339212-03648AA6-E04D-4695-A14F-0AEC46579754

Q37339212-093694B1-7D79-4853-A91E-4ED7AD2037CA

Q37339212-1C77C810-7F3A-4D2C-B6EE-F3B410B5C7C2

Q37339212-240B808E-7A69-4B9A-9E20-34FB9C8DA01E

Q37339212-344B9320-EBCE-4C67-B85A-D2073752EC70

Q37339212-39EE1833-4323-4FBD-BAD8-10781397F3D9

Q37339212-3B1E5ADA-3E99-4EFE-8612-15B45F536238

Q37339212-3E961710-EBBB-4754-9205-F3BA7C69A955

Q37339212-3FEA3225-FE51-48D6-AF4E-6235C055E6D7

Q37339212-402A7442-81A7-4871-92D2-D26168E61BB9

P304

Q37339212-4911CA8B-90A4-432D-9FB6-684E1B6B67A0

P31

Q37339212-1E9D72E0-BE07-4B7E-9BF6-DA6EEAE89B8E

P356

Q37339212-CB9736F4-2869-4C9E-9E96-2A414864220E

P433

Q37339212-C2C2A1E1-08D5-4FFF-9CA2-A31FC1529458

P478

Q37339212-41B15648-246D-45B7-B771-C4492790FCD5

P577

Q37339212-5D5E8DDC-DE75-4148-AD93-2BD96E0BE7E7

P5875

Q37339212-D6CC228E-7DA2-4C0B-97A3-9F8FC72CFCAF

P698

Q37339212-B3A187BE-B725-44EC-A259-247CFE0D5659

P921

Q37339212-BD62B4C4-ACAD-4B47-BDD2-85486D1DD825

P932

Q37339212-0BD29B1E-CBB4-4FA5-B478-DFF755BA7265

P356

J.1537-2995.2011.03232.X

P1433

P1476

Activated T cells from umbilic ...... effects after cord blood trans

@en

P2093

Archana Thakur

http://www.w3.org/2001/XMLSchema#string

Carly Sorenson

http://www.w3.org/2001/XMLSchema#string

Dana Schalk

http://www.w3.org/2001/XMLSchema#string

Lawrence G Lum

http://www.w3.org/2001/XMLSchema#string

Oxana Norkina

http://www.w3.org/2001/XMLSchema#string

Voravit Ratanatharathorn

http://www.w3.org/2001/XMLSchema#string

P2860

High log-scale expansion of functional human natural killer cells from umbilical cord blood CD34-positive cells for adoptive cancer immunotherapy

The earliest T lineage-committed cells depend on IL-7 for Bcl-2 expression and normal cell cycle progression

Differentiation of naive cord-blood T cells into CD19-specific cytolytic effectors for posttransplantation adoptive immunotherapy.

Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

4-1BB and CD28 signaling plays a synergistic role in redirecting umbilical cord blood T cells against B-cell malignancies

Feasibility and safety of adoptive immunotherapy with CIK cells after cord blood transplantation.

The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.

Double umbilical cord blood transplantation.

Identification of a distant T-bet enhancer responsive to IL-12/Stat4 and IFNgamma/Stat1 signals.

P304

63-75

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1537-2995.2011.03232.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51482709

http://www.w3.org/2001/XMLSchema#string

P698

21745212

http://www.w3.org/2001/XMLSchema#string

P921

P932

3839115

http://www.w3.org/2001/XMLSchema#string